Capsugel

Capsugel® Enprotect® capsule enables enteric delivery without the need for a post-filling coating step. This helps protect your sensitive active...

Abstract Biomacromolecules including peptides, proteins, antibodies, and gene medicines, comprise important classes of therapeutics in treating disease. A drawback of...

PRESS RELEASE Basel, Switzerland, 28 May 2026 – Lonza Capsugel has released new peer reviewed research showing that its Licaps® DUOCAP®...

Abstract Background: Rebamipide (REB) is a poorly water-soluble drug with limited ocular bioavailability, necessitating advanced delivery strategies for sustained therapy in...

Abstract Oral delivery of peptides represents a promising alternative to invasive injectable therapies, offering improved patient adherence and convenience. Glucagon-like...

This poster has been presented at the 15th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, which took place in...

The microbiome market In a rapidly growing market, microbiome-based therapies are in high demand, yet many are abandoned due to...

Abstract Background/Objectives: This study aims to investigate the underexplored impact of cap- sule type on the performances of capsule-based dry...

Abstract Enteric-coated dosage forms often suffer from sluggish post-gastric emptying drug release. This work focuses on developing novel enteric polymers...

See our next Live Webinar on the topic of: Lipid-based formulations and enteric capsules to enhance oral bioavailability of peptides...